1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Addex Therapeutics Ltd
  6. News
  7. Summary
    ADXN   CH0029850754

ADDEX THERAPEUTICS LTD

(ADXN)
  Report
Delayed Swiss Exchange  -  07:03 2022-08-16 am EDT
0.2310 CHF   -3.75%
08/15ADDEX THERAPEUTICS : and Indivior Extend GABAB Positive Allosteric Modulator Research Collaboration for Substance Use Disorders - Form 6-K
PU
08/15Addex Therapeutics, Indivior PLC Extend Collaboration Deal, Adds Research Funding
MT
08/15Addex, Indivior to Include Chronic Cough Indication in Research Collaboration
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about ADDEX THERAPEUTICS LTD
08/15ADDEX THERAPEUTICS : and Indivior Extend GABAB Positive Allosteric Modulator Research Coll..
PU
08/15Addex Therapeutics, Indivior PLC Extend Collaboration Deal, Adds Research Funding
MT
08/15Addex, Indivior to Include Chronic Cough Indication in Research Collaboration
MT
08/15Addex and Indivior Extend GABAB Positive Allosteric Modulator Research Collaboration fo..
GL
08/15Addex and Indivior Extend GABAB Positive Allosteric Modulator Research Collaboration fo..
DJ
08/15Addex and Indivior Extend GABAB Positive Allosteric Modulator Research Collaboration fo..
CI
08/12Addex Therapeutics to Report Half-Year 2022 Financial Results and Host Conference Call ..
GL
08/12Addex Therapeutics to Report Half-Year 2022 Financial Results and Host Conference Call ..
AQ
07/27Addex Therapeutics Raises $4 Million In Americal Depositary Receipts Offering
MT
07/26ADDEX THERAPEUTICS : Completes $4.2 Million Equity Financing - Form 6-K
PU
07/26Addex Completes $4.2 Million Equity Financing
GL
07/26Addex Completes $4.2 Million Equity Financing
DJ
07/26Addex Therapeutics Ltd announced that it has received $2.9575 million in funding from A..
CI
07/22Addex Therapeutics Signs $4.2 Million Equity Financing Deal With Armistice Master Fund
MT
07/22ADDEX THERAPEUTICS : Raises $4.2 million in Equity Financing - Form 6-K
PU
More most relevant news
All news about ADDEX THERAPEUTICS LTD
08/15ADDEX THERAPEUTICS : and Indivior Extend GABAB Positive Allosteric Modulator Research Coll..
PU
08/15Addex Therapeutics, Indivior PLC Extend Collaboration Deal, Adds Research Funding
MT
08/15Addex, Indivior to Include Chronic Cough Indication in Research Collaboration
MT
08/15Addex and Indivior Extend GABAB Positive Allosteric Modulator Research Collaboration fo..
GL
08/15Addex and Indivior Extend GABAB Positive Allosteric Modulator Research Collaboration fo..
DJ
08/15Addex and Indivior Extend GABAB Positive Allosteric Modulator Research Collaboration fo..
CI
08/12Addex Therapeutics to Report Half-Year 2022 Financial Results and Host Conference Call ..
GL
08/12Addex Therapeutics to Report Half-Year 2022 Financial Results and Host Conference Call ..
AQ
07/27Addex Therapeutics Raises $4 Million In Americal Depositary Receipts Offering
MT
07/26ADDEX THERAPEUTICS : Completes $4.2 Million Equity Financing - Form 6-K
PU
More news
News in other languages on ADDEX THERAPEUTICS LTD
08/15Addex Therapeutics et Indivior PLC prolongent leur accord de collaboration et ajoutent ..
08/15Addex et Indivior vont inclure l'indication de la toux chronique dans leur collaboratio..
08/15Addex erweitert Zusammenarbeit mit Indivior und sichert sich zusätzliche Mittel
08/15Addex étend sa collaboration avec Indivior
08/15Addex et Indivior étendent leur collaboration en matière de recherche sur les modulateu..
07/27Addex Therapeutics lève 4 millions de dollars dans le cadre d'une offre de certificats ..
07/26Addex a finalisé une augmentation de capital
07/26Addex schliesst Aktienkapitalerhöhung ab
07/22Aktien Schweiz von schwachen Daten belastet
07/22Addex Therapeutics signe un accord de financement par actions de 4,2 millions de dollar..
More news
Analyst Recommendations on ADDEX THERAPEUTICS LTD
06/23HC Wainwright Downgrades Addex Therapeutics to Neutral From Buy
MT
05/31HC Wainwright Adjusts Addex Therapeutics' Price Target to $15 From $21, Keeps Buy Ratin..
MT
02/11HC Wainwright Adjusts Addex Therapeutics' Price Target to $21 from $28, Maintains Buy R..
MT
2021ADDEX THERAPEUTICS : HC Wainwright Initiates Addex Therapeutics at Buy Rating With $28 Pri..
MT
More recommendations
Press releases
08/15ADDEX THERAPEUTICS : and Indivior Extend GABAB Positive Allosteric Modulator Research Coll..
PU
08/15Addex and Indivior Extend GABAB Positive Allosteric Modulator Research Collaboration fo..
GL
08/12Addex Therapeutics to Report Half-Year 2022 Financial Results and Host Conference Call ..
GL
08/12Addex Therapeutics to Report Half-Year 2022 Financial Results and Host Conference Call ..
AQ
07/26ADDEX THERAPEUTICS : Completes $4.2 Million Equity Financing - Form 6-K
PU
More press releases
Upcoming event on ADDEX THERAPEUTICS LTD